Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2012

Sep 10, 2012

31971_dirs_2012-09-10_5d941322-95bd-4a9a-a092-73e7e5ea4583.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-09-06

Reporting Person: CORASANTI EUGENE R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-09-06 Common Stock M 13098 $25.03 Acquired 82812 Direct
2012-09-06 Common Stock S 13098 $27.5391 Disposed 69714 Direct
2012-09-07 Common Stock M 17941 $25.03 Acquired 87655 Direct
2012-09-07 Common Stock S 17941 $27.5059 Disposed 69714 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-06 Options To Purchase Common Stock $25.03 M 13098 Disposed 2014-05-18 Common Stock (13098) Direct
2012-09-07 Options To Purchase Common Stock $25.03 M 17941 Disposed 2014-05-18 Common Stock (17941) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.55. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.